Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - halofuginone lactate - unknown - halofuginone lactate active active 0.0 - active constituent

European Union - English - EMA (European Medicines Agency)

emdoka bvba - halofuginone lactate - halofuginone, other antiprotozoal agents - calves, newborn - in newborn calves:prevention of diarrhoea due to diagnosed cryptosporidium parvum infection, in farms with history of cryptosporidiosis. administration should start in the first 24 to 48 hours of age.reduction of diarrhoea due to diagnosed cryptosporidium parvum infection. administration should start within 24 hours after the onset of diarrhoea. in both cases, the reduction of oocysts excretion has been demonstrated.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

huvepharma eood - halofuginone lactate - unknown - halofuginone lactate active active 0.0 - active constituent

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - halofuginone base as the lactate - oral solution/suspension - halofuginone base as the lactate antiprotozoal active 0.5 g/l - parasiticides - calf | beef calf | bovine | calf - poddy | calf - preweaning | calf - sucker | dairy calf | neonatal calf - diarrheoa cause cryptosporidium parvum | cryptosporidium parvum

United States - English - NLM (National Library of Medicine)

synergy formulas, inc. - tabebuia impetiginosa bark (unii: 6gla1946wx) (tabebuia impetiginosa bark - unii:6gla1946wx), cat's claw (unii: 9060prm18q) (cat's claw - unii:9060prm18q), sus scrofa hypothalamus (unii: n6r0856z79) (sus scrofa hypothalamus - unii:n6r0856z79), sus scrofa pituitary gland (unii: e8s87o660t) (sus scrofa pituitary gland - unii:e8s87o660t), sus scrofa adrenal gland (unii: 398iyq16yv) (sus scrofa adrenal gland - unii:398iyq16yv), nadide (unii: 0u46u6e8uk) (nadide - unii:0u46u6e8uk), lactic acid, dl- (unii: - tabebuia impetiginosa bark 3 [hp_x] in 1 ml - may enhance electron transport systems and absorption of oxygen into the cell. indicated in any condition involving the damaging effect of oxidation, which also increases free radical damage. should be used with detoxosodes for maximum benefit. symptoms of a krebs cycle deficiency may include fatigue, muscle weakness and pain. may enhance electron transport systems and absorption of oxygen into the cell. indicated in any condition involving the damaging effect of oxidation, which also increases free radical damage. should be used with detoxosodes for maximum benefit. symptoms of a krebs cycle deficiency may include fatigue, muscle weakness and pain.

United States - English - NLM (National Library of Medicine)

synergy formulas, inc. - tabebuia impetiginosa bark (unii: 6gla1946wx) (tabebuia impetiginosa bark - unii:6gla1946wx), sus scrofa hypothalamus (unii: n6r0856z79) (sus scrofa hypothalamus - unii:n6r0856z79), sus scrofa pituitary gland (unii: e8s87o660t) (sus scrofa pituitary gland - unii:e8s87o660t), sus scrofa adrenal gland (unii: 398iyq16yv) (sus scrofa adrenal gland - unii:398iyq16yv), nadide (unii: 0u46u6e8uk) (nadide - unii:0u46u6e8uk), lactic acid, dl- (unii: 3b8d35y7s4) (lactic acid, dl- - unii:3b8d35y7s4), lactic acid, - tabebuia impetiginosa bark 3 [hp_x] in 1 ml - may enhance electron transport systems and absorption of oxygen into the cell. indicated in any condition involving the damaging effect of oxidation, which also increases free radical damage. should be used with detoxosodes for maximum benefit. symptoms of a krebs cycle deficiency may include fatigue, muscle weakness and pain. may enhance electron transport systems and absorption of oxygen into the cell. indicated in any condition involving the damaging effect of oxidation, which also increases free radical damage. should be used with detoxosodes for maximum benefit. symptoms of a krebs cycle deficiency may include fatigue, muscle weakness and pain.

United States - English - NLM (National Library of Medicine)

synergy formulas, inc. - tabebuia impetiginosa bark (unii: 6gla1946wx) (tabebuia impetiginosa bark - unii:6gla1946wx), cat's claw (unii: 9060prm18q) (cat's claw - unii:9060prm18q), sus scrofa hypothalamus (unii: n6r0856z79) (sus scrofa hypothalamus - unii:n6r0856z79), sus scrofa pituitary gland (unii: e8s87o660t) (sus scrofa pituitary gland - unii:e8s87o660t), sus scrofa adrenal gland (unii: 398iyq16yv) (sus scrofa adrenal gland - unii:398iyq16yv), nadide (unii: 0u46u6e8uk) (nadide - unii:0u46u6e8uk), lactic acid, l- (unii: f - tabebuia impetiginosa bark 3 [hp_x] in 1 ml - enhances electron transport systems and absorption of oxygen into the cell.  indicated in any condition involving the damaging effect of oxidation, which also increases free radical damage.  should be used with detoxosodes for maximum benefit.   symptoms of a krebs cycle deficiency may include fatigue, muscle weakness and pain. enhances electron transport systems and absorption of oxygen into the cell.  indicated in any condition involving the damaging effect of oxidation, which also increases free radical damage.  should be used with detoxosodes for maximum benefit.   symptoms of a krebs cycle deficiency may include fatigue, muscle weakness and pain.

European Union - English - EMA (European Medicines Agency)

intervet international bv - halofuginone - antiprotozoals - calves, newborn - in newborn calvesprevention of diarrhoea due to diagnosed cryptosporidium parvum in farms with history of cryptosporidiosis.administration should start in the first 24 to 48 hours of age.reduction of diarrhoea due to diagnosed cryptosporidium parvum.administration should start within 24 hours after the onset of diarrhoea.in both cases, the reduction of oocyst excretion has been demonstrated.

European Union - English - EMA (European Medicines Agency)

virbac s.a. - halofuginone - antiprotozoals - calves, newborn - in new born calves:- prevention of diarrhoea due to diagnosed cryptosporidium parvum, in farms with history of cryptosporidiosis,administration should start in the first 24 to 48 hours of age- reduction of diarrhoea due to diagnosed cryptosporidium parvum.administration should start within 24 hours after the onset of diarrhoea.in both cases, the reduction of oocysts excretion has been demonstrated.

Israel - English - Ministry of Health

intervet ( israel) ltd - halofuginone as lactate - solution (oral) - halofuginone as lactate 0.50 mg/ml - in new born calves: prevention of diarrhoea due to diagnosed cryptosporidium parvum, in farms with history of cryptosporidiosis.administration should start in the first 24 to 48 hours of age. reduction of diarrhoea due to diagnosed cryptosporidium parvum. administration should start within 24 hours after the onset of diarrhoea.in both cases, the reduction of ocysts excretion has been demonstrated.